#asia 2026-01-26

japan approved it

transit inside the region ran 25 days for me, which was not faster than a longer route with a better carrier

i keep the compound name and the dose written in the local language in my phone and it has been more useful than any app

as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described

sourcing is physically closer here, why is it not simpler

the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received

a parcel of mine was held inside the region and released after 8 days with no letter and no charge

being closer to the manufacturing does not shorten customs. my parcels from three hours away took as long as ones from europe

the carrier matters more than the distance, and that is the thing this channel took two years to agree on

New independent result logged — WXT, lot A-2601, purity 99% (PeptideMeter).

customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border

is it covered by insurance anywhere in the region
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time

india generics, is that a real landscape now or mostly talk

member reported range

hong kong members reported both clinic and pharmacy routes and a wide price range between the two

japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price, ill dig out the number